AI Article Synopsis

  • Microsponge is a cross-linked particle system that can absorb drugs, similar to a sponge, and can be prepared using different methods.
  • In this study, we utilized a quasi emulsion-solvent diffusion method, combining hydrophobic and hydrophilic polymers along with surfactants like Tween 80 and polyvinyl alcohol to create the formulations.
  • Our findings demonstrate, for the first time, the successful and optimized formulation of microsponge with ketoprofen, exhibiting the desired pharmaceutical properties.

Article Abstract

Microsponge refers to a highly cross-linked particle system with a capacity to adsorb (like a dry sponge) pharmaceutical materials. There are various methods available to prepare microsponge formulations, in this study we used quasi emulsion-solvent diffusion method with a combination of hydrophobic (ethyl cellulose) and hydrophilic (hydroxypropyl methylcellulose) polymers mediated via Tween 80 and polyvinyl alcohol. Various ratios and amounts of the polymers and surfactants were used to prepare microsponge formulations using ketoprofen as a model drug and extensively characterised. Our results, for the first time, indicate successful and optimised formulation with desired pharmaceutical characteristics using a combination of hydrophobic and hydrophilic polymers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2017.11.089DOI Listing

Publication Analysis

Top Keywords

prepare microsponge
8
microsponge formulations
8
combination hydrophobic
8
influence polymer
4
polymer ratio
4
ratio surfactants
4
surfactants controlled
4
controlled drug
4
drug release
4
release cellulosic
4

Similar Publications

Introduction: Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory disease that mostly impacts the joints. Chronotherapeutics refers to a treatment method in which in-vivo drug availability is timed to match rhythms of disease in order to optimize therapeutic outcomes and minimize side effects. Flurbiprofen is a non-steroidal anti-inflammatory drug, indicated for the relief of inflammation.

View Article and Find Full Text PDF

In 1987, Won invented the solid-phase porous microsphere (MS), which stores bioactive compounds in many interconnected voids. Spherical particles (5-300 μm), MS, may form clusters of smaller spheres, resulting in many benefits. The current investigation focussed on gel-encased formulation, which can be suitable for dermal usage.

View Article and Find Full Text PDF

Development of 4-phenylbutyric acid microsponge gel formulations for the treatment of lewisite-mediated skin injury.

Drug Deliv Transl Res

February 2025

Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, 3001 Mercer University Drive, Atlanta, GA 30341, USA.

Lewisite, a chemical warfare agent, causes skin blisters, erythema, edema, and inflammation, requiring mitigation strategies in case of accidental or deliberate exposure. 4-phenyl butyric acid (4-PBA), a chemical chaperone, reduces endoplasmic reticulum stress and skin inflammation. The study aimed to encapsulate 4-PBA in microsponges for effective, sustained delivery against lewisite injury.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!